Giant cells containing Cryptococcus neoformans have been observed by histopathological examination of materials from cases of cryptococcosis in humans (4, 5, 8, 9) . The observation that human leukocytes engulf yeast cells of several pathogenic fungi in vitro was reported by Wang and Schwarz (12) . Drouhet and Segretain (3) reported that cryptococcal polysaccharide inhibits the migration of guinea pig leukocytes. Gadebush (6, 7) demonstrated that a small capsule variant of C. neoformans was phagocytized more readily by leukocytes from anemic mice than was a large capsule variant. As a result of studies with large and small capsule strains, Louria and Kaminski (10) proposed that immunity to cryptococcosis in mice is related to "tissue bound" rather than circulating antibody. Abrahams (1) also suggested that in mice the protective mechanism against cryptococcosis exists primarily at the cellular level.
The isolation of seven nonencapsulated mutants of a human isolate of C. neoformans was reported previously (2a) . The organisms were avirulent for mice. After repeated subculturing, six of the strains reverted to the encapsulated state and regained various degrees of virulence. Since these observations suggest that the capsule may be an important factor in the virulence of C. neoformans, it was decided to investigate possible differences between these strains and the parent encapsulated organism with regard to phagocytosis. This paper, and the ensuing one, report on the in vitro phagocytosis of C. neoformans by human leukocytes, the differences in percentage of phagocytosis between the encapsulated parent strain and seven nonencapsulated mutants, and the inhibition of phagocytosis by cryptococcal capsular material.
MATERIALS AND METHODS
Eight strains of C. neoformanis were used in these studies: CIA, an encapsulated strain of human origin, and seven mutants, which, upon original isolation following ultraviolet light irradiation of CIA, were nonencapsulated and avirulent for mice. The isolation and maintenance procedures for these organisms were reported previously (2a) .
Preliminary studies were performed to determine whether human leukocytes could phagocytize cells of C. neoformans in vitro. Single drops of whole blood from finger punctures were allowed to clot on a clean microscope cover slip. Within 30 min leukocytes adhered to the cover slip and the fibrin clot was removed. Cells of C. neoformanis suspended in autologous serum were added to the leukocyte preparation. Visual observations were made with the aid of a phase-contrast microscope.
All subsequent phagocytosis experiments were conducted with freshly collected human blood. Healthy technicians, students, and faculty members of the University of Oklahoma School of Medicine served as donors. Serum used for the cryptococcal suspending medium was obtained from 20 ml of blood which was drawn aseptically by venipuncture and allowed to clot in sterile tubes.
The method of Braunsteiner et al. (2) was used for the isolation of 75 to 85% of the leukocytes in the blood samples. A 20-gauge disposable needle affixed to a 20-ml plastic syringe containing 100 units of heparin was used for venipuncture. A 10-ml amount of venous blood was drawn into the syringe and 4 ml of a 3.5% solution of polyvinylpyrrolidone (type NP-K30) in 0.9% NaCI was added immediately. The needle was removed from the syringe and replaced with another 20-gauge disposable needle. The syringe was rotated momentarily and placed at a 450 angle in a 500-ml beaker with the needle pointed upward. After 1 hr at 8 C the syringe was removed from the beaker, the needle was bent to a 450 angle, and the supernatant fluid was expelled carefully into a siliconized glass tube (13 X 100 mm) by pressing slowly upward on the plunger of the syringe. The (11) .
One ml of a 2 X 106 to 4 X 106 cryptococcal cell suspension in autologous serum and 1 ml of the leukocyte suspension were added to siliconized glass tubes (13 X 100 mm). The tubes were placed vertically in an Eberbach Rotator in a 37 C incubator and shaken at 180 oscillations/min for 1 hr. A drop of the mixture from each tube was then placed on a microscope slide, air-dried, and stained with Wright's stain. The slides were examined microscopically with the aid of an oil immersion lens. One hundred leukocytes were counted, and the number of leukocytes containing cryptococcal cells was recorded as the percentage of phagocytosis. The phagocytic index was determined by counting the number of yeast cells ingested per 100 phagocytes.
RESULTS
The leukocytes in the finger puncture preparations appeared very active, with extending pseudopods and numerous rapidly moving cytoplasmic granules. Within a few minutes, it was readily apparent that the granulocytes had engulfed some of the yeast cells. The phagocytic process appeared to be no different from that described for other particulate matter. The entire process required less than 2 min after initial contact between the cell and phagocyte. It is possible, however, that the heat generated by the microscope lamp may have artificially increased the activity of the leukocytes. As far as could be determined, the neutrophil was the principal phagocytic cell.
When the nonencapsulated mutants, Ml through M7, were used in place of the encapsulated parent strain, active phagocytosis by neutrophils was observed (Fig. 1) . Attempts to quantitate the differences in phagocytic activity between CIA and the nonencapsulated mutants were not successful. However, it was obvious that more mutants than encapsulated parent cells were engulfed per phagocyte.
The inability to obtain quantitative data and the limitations as to the types of experiments that could be conducted with the slide method prompted a change to the tube procedure.
Sera and leukocytes from 15 individuals were tested for phagocytic activity against the encapsulated strain CIA. An average of 24% of the leukocytes engulfed yeast cells (Table 1, The sera and leukocytes of 35 individuals were tested for phagocytic activity against cells of the (2a), six of the seven mutants began to revert to the encapsulated state after 5 months of weekly subculturing. After 12 months of subculturing, a high percentage of the cells of Ml through M6 were encapsulated (Table  1 , column 4). The cells of M7 remained nonencapsulated. As shown in Table 1 , the percentage of phagocytosis for Ml through M6 after reversion to the encapsulated state ranged from 24 to 68, with a mean of 48. At this time, an average of 74% of the cells in these strains were encapsulated. In contrast, the average percentage of phagocytosis was 78 when none of the six strains had a capsule. Throughout the subculturing process, M7 remained nonencapsulated and the percentage of phagocytosis remained high i.e., 79% after original isolation and 72% after 12 months of subculturing. The percentage of phagocytosis for the encapsulated parent strain remained low, i.e., 24% originally and 26% after 12 months of subculturing.
DISCUSSION
In a series of preliminary experiments in which human leukocytes were incubated with a human isolate of encapsulated C. neoformans on a microscope slide and observed through a phase-contrast microscope, the actual engulfment of yeast cells was seen. Phagocytosis of nonencapsulated mutants of C. neoformans was also followed. Although the latter cells appeared to be engulfed more readily by leukocytes than were cells of the encapsulated strain, it was difficult to quantitate These data suggest that the capsule of C. neoformans inhibits the phagocytosis of the organism. Quantitative data on the inhibition of phag-
